Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

Fig. 2

The cumulative incidence of HCC in patients with AF P < 6.0 ng/ml. a Patients were stratified by the median of AFP (P = 0.723). The cumulative incidence of HCC at year 4 of patients with AF P < median and median are 0.05 and 0.06 respectively. b Patients were stratified by the median of IL-17 (P = 0.086). The cumulative incidence of HCC at year 4 of patients with IL-17 < median and median are 0.03 and 0.08 respectively

Back to article page